Meet Syncrosome a world leader CRO dedicated to preclinical research

Are you attending « Preclinical Safety and Efficacy Testing for New Drugs » Annual meeting in Zurich?

I would like to invite you to meet Syncrosome representatives:

  • Sandra Robelet, CNS Study Director,
  • Emmanuelle Bettendorf, Account Manager,

at « Preclinical Safety and Efficacy Testing for New Drugs », Nov. 29 – Dec. 1 in Zurich.

Syncrosome is a Preclinical Drug Evaluation Company specialised in human health – we perform pharmacological in vivo studies on physiopathological models.

Our expertise is focused on:

* Proof of concept in vivo with Central Nervous System (Parkinson & Stroke), Cardiovascular (Heart Failure, Pulmonary Arterial Hypertension), Respiratory (Asthma & BPCO) and Gastroenterological (IBD & Emesis) models in routine.

* Early bioavailibility and CNS-PK on different species with a high competence in the study of the Blood Brain Barrier passage. Indeed, Microdialysis and CSF sampling are 2 in routine services.

* Neurotranmitters and Drugs levels assessment.

Based on our expertise and experience Syncrosome offers customized solution to clients from Pharmaceutical Industry and Biotechnologies company.

Aucune réaction sur “Meet Syncrosome a world leader CRO dedicated to preclinical research”

Laisser une réponse:

Nom (obligatoire):
Mail (ne sera pas publié) (obligatoire):
Site Internet:
Commentaire (obligatoire):
XHTML: Vous pouvez utiliser ces balises: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
Waygo : Agence webmarketing